Paul K. Ng
University of California, Berkeley
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul K. Ng.
Hepatology | 2004
Christopher J. Parsons; Blair U. Bradford; Clark Pan; Ellen Cheung; Michael Schauer; Andreas Knorr; Barbara Krebs; Sabine Kraft; Stefan Zahn; Bodo Brocks; Nikki Feirt; Baisong Mei; Myung-Sam Cho; Roopa Ramamoorthi; Greg Roldan; Paul K. Ng; Peggy Lum; Claudia Hirth-Dietrich; Adrian Tomkinson; David A. Brenner
Liver fibrosis is characterized by increased synthesis, and decreased degradation, of extracellular matrix (ECM) within the injured tissue. Decreased ECM degradation results, in part, from increased expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1), which blocks matrix metalloproteinase (MMP) activity. TIMP‐1 is also involved in promoting survival of activated hepatic stellate cells (HSCs), a major source of ECM. This study examined the effects of blocking TIMP‐1 activity in a clinically relevant model of established liver fibrosis. Rats were treated with carbon tetrachloride (CCl4), or olive oil control, for 6 weeks; 24 days into the treatment, the rats were administered a neutralizing anti–TIMP‐1 antibody derived from a fully human combinatorial antibody library (HuCAL), PBS, or an isotype control antibody. Livers from CCl4‐treated rats exhibited substantial damage, including bridging fibrosis, inflammation, and extensive expression of smooth muscle α‐actin (α‐SMA). Compared to controls, rats administered anti–TIMP‐1 showed a reduction in collagen accumulation by histological examination and hydroxyproline content. Administration of anti–TIMP‐1 resulted in a marked decrease in α‐SMA staining. Zymography analysis showed antibody treatment decreased the activity of MMP‐2. In conclusion, administration of a TIMP‐1 antibody attenuated CCl4‐induced liver fibrosis and decreased HSC activation and MMP‐2 activity. (HEPATOLOGY 2004.)
Separation Science and Technology | 1976
Paul K. Ng; John L. Lundblad; Gautam Mitra
Abstract Preliminary consideration suggests that process time in diafiltration can be optimized. A mathematical derivation of the optimum time gives a surprisingly simple general relationship between the bulk concentration and the membrane surface concentration. Experimental values confirm that an optimum value can indeed be obtained.
Transfusion | 1981
Paul K. Ng; Fournel Ma; Lundblad Jl
The vasodilative effects associated with the use of sodium acetate have been reported in the literature. Preparations of plasma protein fraction (PPF) substantially free of this vasodilator were developed. This paper presents and discusses experimental work on the improved product.
Vox Sanguinis | 1993
Paul K. Ng; Peter E. O'Rourke; John D. Andersen; Grace C. Tsay; Milton B. Dobkin
An IgM concentrate was purified from Cohn fraction III. Efficiency of euglobin precipitation was shown to be controlled by pH and ionic strength. Prekallikrein activator activity in the product was insignificant. Overall yield from the octanoic acid supernate and purity of the concentrate were 66 ± 8 (n = 16) and 50 ± 5% (n = 16), respectively. Solvent‐detergent treatment to inactivate lipid‐enveloped viruses was demonstrated and implemented into the process. Process studies to control residual virucidal agents and C4a generating activity are presented.
Separation Science and Technology | 1990
Paul K. Ng; I. Andrew Obegi
Abstract Tangential flow cell separation from fermenter-derived mammalian cell culture has been studied. The process is governed by transmembrane pressure and interactions of carry-over cells with the membrane. Membrane regeneration and comparison with other cell separation systems were discussed. Higher throughput per unit area over conventional dead end filter was demonstrated.
Archive | 1981
Paul K. Ng; Michael A. Fournel
Journal of Pharmaceutical Sciences | 1978
Paul K. Ng; Gautam Mitra; John L. Lundblad
Archive | 1981
Paul K. Ng; Milton B. Dobkin
Biotechnology and Bioengineering | 1982
Gautam Mitra; Paul K. Ng; A. Laudermilch; John L. Lundblad
Vox Sanguinis | 1994
Gautam Mitra; Milton B. Dobkin; M. Dumas; Paul K. Ng; G. Roldan; C. Galloway